Hyundai ADM Bio Inc. (187660) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hyundai ADM Bio Inc. (187660:KRX), powered by AI.

Current Price
₩9,770
P/E Ratio
-36.5
Market Cap
541.9B
Sector
Healthcare
What is the Hyundai ADM Bio Inc. stock price forecast?

Hyundai ADM Bio Inc. is currently trading at ₩9,770. View real-time AI analysis on Alpha Lenz.

What is Hyundai ADM Bio Inc. insider trading activity?

View the latest insider trading data for Hyundai ADM Bio Inc. on Alpha Lenz.

What is Hyundai ADM Bio Inc.'s P/E ratio?

Hyundai ADM Bio Inc.'s P/E ratio is -36.5.

Hyundai ADM Bio Inc.

KRX · 187660
₩9,770-80(-0.81%)Market closedKRX regular session 09:00–15:30 KST
Ask about Hyundai ADM Bio Inc.'s future dividend policy...
Alpha Chat Insight

Hyundai ADM Bio Inc. trades at a P/E of -36.5 (undervalued) with modest ROE of -104.6%.

Ask for details

Company Overview

Hyundai ADM Bio Inc. operates within the biotechnology sector, focusing on the development and production of advanced biomaterials. The primary purpose of the company is to innovate and manufacture sustainable and eco-friendly materials that can be utilized across various industries, including medical, agricultural, and consumer goods. One of the notable features of Hyundai ADM Bio Inc. is its emphasis on integrating biotechnology with traditional material science to create products that meet modern environmental standards. By leveraging cutting-edge research and development, the company aims to provide solutions that contribute to a more sustainable future. Hyundai ADM Bio Inc.'s operations significantly impact sectors such as health care, where biocompatible materials are essential, and agriculture, where biodegradable products can enhance sustainability. Its role in the market is critical as it addresses the growing demand for environmentally-friendly alternatives in material manufacturing, thereby supporting industries in reducing their carbon footprint and improving ecological balance.

CEO조원동, 진근우(공동 대표이사)
SectorHealthcare
IndustryMedical Care Facilities
Employees160

Company Statistics

FY 2025

Profile

₩541,905,291,810Market Cap
₩9,273,012,790Revenue
55.47MShares Out
160Employees

Margins

0.36%Gross
-61.83%EBITDA
-79.55%Operating
-158.67%Pre-Tax
-159.92%Net

Valuation

-36.54P/E
25.17P/B
58.44EV/Sales
-94.63EV/EBITDA
-103.26P/FCF

Growth (CAGR)

-14.59%Rev 3Yr
-6.71%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-48.37%ROA
-104.62%ROE
-42.20%ROIC

Financial Health

₩4,780,410,370Cash & Cash Equivalents
₩6,484,809,320Net Debt
52.33%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Hyundai ADM Bio Inc. (ticker: 187660) is a company listed on KRX in the Healthcare sector (Medical Care Facilities). It has approximately 160 employees. Market cap is $541.9B.

The current price is ₩9,770 with a P/E ratio of -36.54x and P/B of 25.17x.

ROE is -104.62% and operating margin is -79.55%. Annual revenue is $9.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Hyundai ADM Bio Inc. (Healthcare) Stock Forecast & Analysis ₩9,770 | Alpha Lenz